Profile data is unavailable for this security.
About the company
New Horizon Health Ltd is a China-based investment holding company principally engaged in the research, development, clinical development, test operation and commercialization of screening products for colorectal cancer, gastric cancer and cervical cancer. The Company distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.
- Revenue in HKD (TTM)1.47bn
- Net income in HKD119.37m
- Incorporated2018
- Employees1.04k
- LocationNew Horizon Health Ltd13/F, T1 Building400 Jiang'er RoadBinjiang DistrictHANGZHOU ChinaCHN
- Websitehttps://ir.newhorizonbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consun Pharmaceutical Group Ltd | 2.79bn | 846.58m | 4.94bn | 3.13k | 5.74 | 1.26 | 5.29 | 1.77 | 1.06 | 1.06 | 3.50 | 4.83 | 0.4981 | 2.08 | 9.10 | 893,815.30 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Ocumension Therapeutics | 265.85m | -409.82m | 4.97bn | 444.00 | -- | 1.57 | -- | 18.71 | -0.6316 | -0.6316 | 0.4095 | 4.56 | 0.078 | 3.61 | 2.12 | 598,764.60 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Alphamab Oncology | 236.08m | -227.25m | 5.01bn | 435.00 | -- | 2.78 | -- | 21.21 | -0.2363 | -0.2363 | 0.2459 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,704.00 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.20bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 667.02m | -128.82m | 5.22bn | 813.00 | -- | 3.66 | -- | 7.82 | -0.2529 | -0.2529 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | 820,436.90 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.26bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Ascentage Pharma Group International | 239.54m | -998.84m | 5.34bn | 583.00 | -- | 81.90 | -- | 22.29 | -3.53 | -3.53 | 0.8485 | 0.2247 | 0.0833 | 2.38 | 2.22 | 410,875.00 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -269.07m | 5.47bn | 133.00 | -- | 4.96 | -- | -- | -1.34 | -1.34 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 0.00 | -513.13m | 5.69bn | 323.00 | -- | 13.28 | -- | -- | -2.31 | -2.31 | 0.00 | 1.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -64.02 | 0.4436 | -- | -- | -- | 27.45 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.29m | 5.69bn | 2.87k | -- | 1.19 | -- | 2.83 | -0.0063 | -0.0063 | 0.216 | 0.5126 | 0.1572 | 0.8101 | 4.72 | 699,054.30 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| New Horizon Health Ltd | 1.47bn | 119.37m | 6.47bn | 1.04k | 59.20 | 2.01 | 41.64 | 4.40 | 0.2389 | 0.2389 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,673,916.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 873.23m | 110.27m | 6.63bn | 948.00 | 20.06 | 0.8752 | -- | 7.59 | 0.1072 | 0.1072 | 0.8293 | 2.46 | 0.2852 | 1.44 | 1.62 | 921,131.60 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Tong Ren Tang Technologies Co Ltd | 7.31bn | 636.86m | 6.98bn | 4.10k | 10.96 | 0.9389 | 5.10 | 0.955 | 0.4972 | 0.4972 | 5.71 | 5.80 | 0.5212 | 0.9835 | 5.68 | 1,782,287.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 7.69bn | 3.44k | 6.72 | 1.01 | 6.28 | 1.58 | 1.38 | 1.38 | 6.45 | 9.18 | 0.5073 | 1.44 | 6.31 | 1,418,434.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 7.89bn | 798.00 | 14.59 | 2.04 | 11.72 | 5.17 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Everest Medicines Ltd | 135.89m | -911.25m | 8.09bn | 432.00 | -- | 1.49 | -- | 59.52 | -2.91 | -2.91 | 0.4341 | 16.79 | 0.0203 | 2.25 | 4.57 | 314,563.90 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Data as of Mar 27 2024. Currency figures normalised to New Horizon Health Ltd's reporting currency: Hong Kong Dollar HKD
21.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Advisers, Inc.as of 02 May 2024 | 30.13m | 6.58% |
| Janus Henderson Investors US LLCas of 05 Apr 2024 | 15.83m | 3.46% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 13.19m | 2.88% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 9.12m | 1.99% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 7.52m | 1.64% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 4.74m | 1.04% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2023 | 4.29m | 0.94% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 4.16m | 0.91% |
| RBC Global Asset Management (Asia) Ltd.as of 29 Feb 2024 | 4.00m | 0.87% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 3.42m | 0.75% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
